Resistance to Cancer Immune Therapy: TNF Signaling - Hallo friendsLET'S HEALTHY LIFE, In the article you read this time with the title Resistance to Cancer Immune Therapy: TNF Signaling, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cough, Article diabetes, Article diseases, Article in general, Article Phytotherapy, Article skin diseases, We write this you can understand. Alright, good read.

Title : Resistance to Cancer Immune Therapy: TNF Signaling
link : Resistance to Cancer Immune Therapy: TNF Signaling

Resistance to Cancer Immune Therapy: TNF Signaling

Resistance to cancer immune therapy seems to involve downregulation of tumor necrosis factor (TNF) signaling, which possibly in the future can be a focal point of new therapies to make immune-based treatment more effective.  Abstract:

Immunotherapy has revolutionized outcomes for cancer patients, but the mechanisms of resistance remain poorly defined. We used a series of whole-genome clustered regularly interspaced short palindromic repeat (CRISPR)-based screens performed in vitro and in vivo to identify mechanisms of tumor immune evasion from cytotoxic lymphocytes [CD8+ T cells and natural killer (NK) cells]. Deletion of key genes within the tumor necrosis factor (TNF) signaling, interferon-γ (IFN-γ) signaling, and antigen presentation pathways provided protection of tumor cells from CD8+ T cell-mediated killing and blunted antitumor immune responses in vivo. Deletion of a number of genes in the TNF pathway also emerged as the key mechanism of immune evasion from primary NK cells. Our screens also identified that the metabolic protein 2-aminoethanethiol dioxygenase (Ado) modulates sensitivity to TNF-mediated killing by cytotoxic lymphocytes and is required for optimal control of tumors in vivo. Remarkably, we found that tumors delete the same genes when exposed to perforin-deficient CD8+ T cells, demonstrating that the dominant immune evasion strategy used by tumor cells is acquired resistance to T cell-derived cytokine-mediated antitumor effects. We demonstrate that TNF-mediated bystander killing is a potent T cell effector mechanism capable of killing antigen-negative tumor cells. In addition to highlighting the importance of TNF in CD8+ T cell- and NK cell-mediated killing of tumor cells, our study also provides a comprehensive picture of the roles of the TNF, IFN, and antigen presentation pathways in immune-mediated tumor surveillance.

Thus Article Resistance to Cancer Immune Therapy: TNF Signaling

That's an article Resistance to Cancer Immune Therapy: TNF Signaling This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Resistance to Cancer Immune Therapy: TNF Signaling with the link address https://letslifes.blogspot.com/2018/12/resistance-to-cancer-immune-therapy-tnf.html

Tweet

Subscribe to receive free email updates: